These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 20538613)
1. Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype. Sánchez-Cenizo L; Formentini L; Aldea M; Ortega AD; García-Huerta P; Sánchez-Aragó M; Cuezva JM J Biol Chem; 2010 Aug; 285(33):25308-13. PubMed ID: 20538613 [TBL] [Abstract][Full Text] [Related]
2. The ATPase Inhibitory Factor 1 (IF1): A master regulator of energy metabolism and of cell survival. García-Bermúdez J; Cuezva JM Biochim Biophys Acta; 2016 Aug; 1857(8):1167-1182. PubMed ID: 26876430 [TBL] [Abstract][Full Text] [Related]
3. PKA Phosphorylates the ATPase Inhibitory Factor 1 and Inactivates Its Capacity to Bind and Inhibit the Mitochondrial H(+)-ATP Synthase. García-Bermúdez J; Sánchez-Aragó M; Soldevilla B; Del Arco A; Nuevo-Tapioles C; Cuezva JM Cell Rep; 2015 Sep; 12(12):2143-55. PubMed ID: 26387949 [TBL] [Abstract][Full Text] [Related]
4. Glucose-modulated mitochondria adaptation in tumor cells: a focus on ATP synthase and inhibitor Factor 1. Domenis R; Bisetto E; Rossi D; Comelli M; Mavelli I Int J Mol Sci; 2012; 13(2):1933-1950. PubMed ID: 22408432 [TBL] [Abstract][Full Text] [Related]
5. Regulation of the H Esparza-Moltó PB; Nuevo-Tapioles C; Cuezva JM Cell Mol Life Sci; 2017 Jun; 74(12):2151-2166. PubMed ID: 28168445 [TBL] [Abstract][Full Text] [Related]
6. The role of the ATPase inhibitor factor 1 (IF Sgarbi G; Barbato S; Costanzini A; Solaini G; Baracca A Biochim Biophys Acta Bioenerg; 2018 Feb; 1859(2):99-109. PubMed ID: 29097244 [TBL] [Abstract][Full Text] [Related]
7. In vivo inhibition of the mitochondrial H+-ATP synthase in neurons promotes metabolic preconditioning. Formentini L; Pereira MP; Sánchez-Cenizo L; Santacatterina F; Lucas JJ; Navarro C; Martínez-Serrano A; Cuezva JM EMBO J; 2014 Apr; 33(7):762-78. PubMed ID: 24521670 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of the mitochondrial ATPase function by IF1 changes the spatiotemporal organization of ATP synthase. Weissert V; Rieger B; Morris S; Arroum T; Psathaki OE; Zobel T; Perkins G; Busch KB Biochim Biophys Acta Bioenerg; 2021 Jan; 1862(1):148322. PubMed ID: 33065099 [TBL] [Abstract][Full Text] [Related]
9. The F1Fo-ATPase inhibitor, IF1, is a critical regulator of energy metabolism in cancer cells. Solaini G; Sgarbi G; Baracca A Biochem Soc Trans; 2021 Apr; 49(2):815-827. PubMed ID: 33929490 [TBL] [Abstract][Full Text] [Related]
10. The inhibitor protein (IF1) of the F1F0-ATPase modulates human osteosarcoma cell bioenergetics. Barbato S; Sgarbi G; Gorini G; Baracca A; Solaini G J Biol Chem; 2015 Mar; 290(10):6338-48. PubMed ID: 25605724 [TBL] [Abstract][Full Text] [Related]
11. The Multifaceted ATPase Inhibitory Factor 1 (IF1) in Energy Metabolism Reprogramming and Mitochondrial Dysfunction: A New Player in Age-Associated Disorders? Gore E; Duparc T; Genoux A; Perret B; Najib S; Martinez LO Antioxid Redox Signal; 2022 Aug; 37(4-6):370-393. PubMed ID: 34605675 [No Abstract] [Full Text] [Related]
12. ATP synthase inhibitory factor subunit 1 regulates islet β-cell function via repression of mitochondrial homeostasis. Zhang K; Bao R; Huang F; Yang K; Ding Y; Lauterboeck L; Yoshida M; Long Q; Yang Q Lab Invest; 2022 Jan; 102(1):69-79. PubMed ID: 34608240 [TBL] [Abstract][Full Text] [Related]
13. Mitochondrial H Formentini L; Ryan AJ; Gálvez-Santisteban M; Carter L; Taub P; Lapek JD; Gonzalez DJ; Villarreal F; Ciaraldi TP; Cuezva JM; Henry RR Diabetologia; 2017 Oct; 60(10):2052-2065. PubMed ID: 28770317 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of the ATPase Inhibitory Factor 1 Favors a Non-metastatic Phenotype in Breast Cancer. García-Ledo L; Nuevo-Tapioles C; Cuevas-Martín C; Martínez-Reyes I; Soldevilla B; González-Llorente L; Cuezva JM Front Oncol; 2017; 7():69. PubMed ID: 28443245 [TBL] [Abstract][Full Text] [Related]
15. Peptides Targeting the IF1-ATP Synthase Complex Modulate the Permeability Transition Pore in Cancer HeLa Cells. Grandi M; Fabbian S; Solaini G; Baracca A; Bellanda M; Giorgio V Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731874 [TBL] [Abstract][Full Text] [Related]
16. The mitochondrial inhibitor IF1 binds to the ATP synthase OSCP subunit and protects cancer cells from apoptosis. Galber C; Fabbian S; Gatto C; Grandi M; Carissimi S; Acosta MJ; Sgarbi G; Tiso N; Argenton F; Solaini G; Baracca A; Bellanda M; Giorgio V Cell Death Dis; 2023 Jan; 14(1):54. PubMed ID: 36690622 [TBL] [Abstract][Full Text] [Related]
17. IF1 ablation prevents ATP synthase oligomerization, enhances mitochondrial ATP turnover and promotes an adenosine-mediated pro-inflammatory phenotype. Domínguez-Zorita S; Romero-Carramiñana I; Santacatterina F; Esparza-Moltó PB; Simó C; Del-Arco A; Núñez de Arenas C; Saiz J; Barbas C; Cuezva JM Cell Death Dis; 2023 Jul; 14(7):413. PubMed ID: 37433784 [TBL] [Abstract][Full Text] [Related]
18. Post-transcriptional regulation of the mitochondrial H(+)-ATP synthase: a key regulator of the metabolic phenotype in cancer. Willers IM; Cuezva JM Biochim Biophys Acta; 2011 Jun; 1807(6):543-51. PubMed ID: 21035425 [TBL] [Abstract][Full Text] [Related]
19. IF1, a natural inhibitor of mitochondrial ATP synthase, is not essential for the normal growth and breeding of mice. Nakamura J; Fujikawa M; Yoshida M Biosci Rep; 2013 Sep; 33(5):. PubMed ID: 23889209 [TBL] [Abstract][Full Text] [Related]
20. [Research on relevance between mitochondrial ATP synthase and malignant tumor]. Wang J; Li R; Zhang G Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2014 Jun; 31(3):714-7. PubMed ID: 25219263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]